Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.
Saunders, Mark P
Wardley, Andrew M
AffiliationUniversity of Manchester, School of Nursing, University Place, Manchester, M13 9PL, United Kingdom. email@example.com
MetadataShow full item record
AbstractPURPOSE: To assess the effectiveness of a symptom-focused home care program in patients with cancer who were receiving oral chemotherapy in relation to toxicity levels, anxiety, depression, quality of life, and service utilization. PATIENTS AND METHODS: A randomized, controlled trial was carried out with 164 patients with a diagnosis of colorectal (n = 110) and breast (n = 54) cancers who were receiving oral capecitabine. Patients were randomly assigned to receive either a home care program by a nurse or standard care for 18 weeks (ie, six cycles of chemotherapy). Toxicity assessments were carried out weekly for the duration of the patients' participation in the trial, and validated self-report tools assessed anxiety, depression, and quality of life. RESULTS: Significant improvements were observed in the home care group in relation to the symptoms of oral mucositis, diarrhea, constipation, nausea, pain, fatigue (first four cycles), and insomnia (all P < .05). This improvement was most significant during the initial two cycles. Unplanned service utilization, particularly the number of inpatient days (57 v 167 days; P = .02), also was lower in the home care group. CONCLUSION: A symptom-focused home care program was able to assist patients to manage their treatment adverse effects more effectively than standard care. It is imperative that patients receiving oral chemotherapy are supported with such programs, particularly during initial treatment cycles, to improve their treatment and symptom experiences.
CitationEffectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. 2009, 27 (36):6191-8 J. Clin. Oncol.
JournalJournal of Clinical Oncology
- Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer.
- Authors: Craven O, Hughes CA, Burton A, Saunders MP, Molassiotis A
- Issue date: 2013 May
- A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences.
- Authors: MacLeod A, Branch A, Cassidy J, McDonald A, Mohammed N, MacDonald L
- Issue date: 2007 Jul
- Implications of capecitabine (Xeloda) for cancer nursing practice.
- Authors: Gerbrecht BM, Kangas T
- Issue date: 2004
- Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.
- Authors: Twelves C, Boyer M, Findlay M, Cassidy J, Weitzel C, Barker C, Osterwalder B, Jamieson C, Hieke K, Xeloda Colorectal Cancer Study Group.
- Issue date: 2001 Mar
- Quality of life of cancer patients receiving inpatient and home-based palliative care.
- Authors: Peters L, Sellick K
- Issue date: 2006 Mar